Your browser doesn't support javascript.
loading
Expression of PD-L1 through evolution phase from pre-invasive to invasive lung adenocarcinoma.
Zhou, Jiebai; Lin, Huo; Ni, Zheng; Luo, Rongkui; Yang, Dawei; Feng, Mingxiang; Zhang, Yong.
Affiliation
  • Zhou J; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Lin H; Department of Pulmonary and Critical Care Medicine, Shishi County Hospital, Shishi, Fujian, China.
  • Ni Z; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Luo R; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Yang D; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Feng M; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China. feng.mingxiang@zs-hospital.sh.cn.
  • Zhang Y; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China. zhang.yong@zs-hospital.sh.cn.
BMC Pulm Med ; 23(1): 18, 2023 Jan 16.
Article de En | MEDLINE | ID: mdl-36647116
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Adénocarcinome in situ / Adénocarcinome pulmonaire / Tumeurs du poumon Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: BMC Pulm Med Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Adénocarcinome in situ / Adénocarcinome pulmonaire / Tumeurs du poumon Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: BMC Pulm Med Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: Royaume-Uni